Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers

British Journal of Cancer

Volumn 76, Issue 9, 1997, Pages 1150-1156

  Collins, N ^a   Wooster, R ^a,b   Stratton, M R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DINUCLEOTIDE; RESTRICTION ENDONUCLEASE; VIRUS LARGE T ANTIGEN;

ARTICLE; BREAST CANCER; CELL IMMORTALIZATION; CHROMOSOME 13Q; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE REPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LEUKOCYTE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0030818584     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.526     Document Type: Article

References (32)

1. Bird AP (1986) CpG-rich islands and the function of DNA methylation. Nature 321: 209-213
2. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma [published erratum appears in Nature Genet 1994 Dec: 8(4): 410]. Nature Genet 8: 27-32
3. Cleton-Jansen A-M, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ and Stratton MR (1995) Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 72: 1241-1244
4. Collins N, McManus R, Wooster R, Mangion J, Seal S, Lakhani SR, Ormiston W, Daly PA, Ford D, Easton DF and Stratton MR (1995) Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 10: 1673-1675
5. Cornelis RS, Neuhausen SL, Johansson O, Arason A, Kelsell D, Ponder BA, Tonin P, Hamann U, Lindblom A, Lalle P, Longy M, Olah E, Scherneck S, Bignon YJ, Sobol H, Chang-Claude J, Larsson C, Spurr N, Borg A, Barkardottir RB, Narod S and Devilee P and the Breast Cancer Linkage Consortium (1995) High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCA1-linked families. The Breast Cancer Linkage Consortium. Genes Chrom Cancer 13: 203-210
6. Cropp CS, Champeme MH, Lidereau R and Callahan R (1993) Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. Cancer Res 53: 5617-5619
7. Devilee P, van den Broek M, Kuipers Dijkshoorn N, Kolluri R, Khan PM, Pearson PL and Cornelisse CJ (1989) At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5: 554-560
8. Foster KA, Harrington P, Kerr J, Russell P, DiCioccio RA, Scott IV, Jacobs I, Chenevix Trench G, Ponder BA and Gayther SA (1996) Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res 56: 3622-3625
9. Futreal PA, Liu Q, Shattuck Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger D, Barrett JC, Skolnick M, Kamb A and Wiseman R (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122
10. Gessler M, Konig A, Arden K, Grundy P, Orkin S, Sallan S, Peters C, Ruyle S, Mandell J and Li F (1994) Infrequent mutation of the WT1 gene in 77 Wilms' tumors. Hum Mutat 3: 212-222
11. Gonzalez Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-1535
12. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM and Baylin S (1994) Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA 91: 9700-9704
13. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D and Baylin SB (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530
14. Hosking L, Trowsdale J, Nicolai H, Solomon E, Foulkes W, Stamp G, Signer E and Jeffreys A (1995) A somatic BRCA1 mutation in an ovarian tumour (letter). Nature Genet 9: 343-344
15. Kerangueven F, Allione F, Noguchi T, Adelaide J, Sobol H, Jacquemier J and Birnbaum D (1995) Patterns of loss of heterozygosity at loci from chromosome arm 13q suggests a possible involvement of BRCA2 in sporadic breast tumors. Genes Chrom Cancer 13: 291-294
16. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR and Futreal PA (1996) BRCA2 mutations in primary breast and ovarian cancers. Nature Genet 13: 238-240
17. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Koper JW, Avezaat CJ and Kley N (1994) Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54: 1022-1029
18. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R and Cawthorn R (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69: 275-281
19. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C and Frank TS (1995) Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet 9: 439-443
20. Miki Y, Swensen J, Shattuck Eidens D, Futreal PA, Harshman K, Tavtigian S, Lin Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayanath P, Ward J, Tonin P, Narod S, Bristow P, Norris F, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick M (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71
21. Miki Y, Katagiri T, Kasumi F, Yoshimoto T and Nakamura Y (1996) Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet 13: 245-247
22. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris C and Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708
23. Ohtani Fujita N, Fujita T, Aoike A, Osifchin NE, Robbins PD and Sakai T (1993) CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 8: 1063-1067
24. Powell SM, Zilz N, Beazer Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B and Kinzler KW (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235-237
25. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman M and Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54: 2852-2855
26. Tang A, Varley JM, Chakraborty S, Murphree AL and Fung YK (1988) Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 242: 263-266
27. Takahashi H, Chiu HC, Bandera CA, Behbakht K, Liu PC, Couch FJ, Weber BL, LiVolsi VA, Furusato M, Rebane BA, Cardonick A, Benjamin I, Morgan MA, King SA, Mikuta JJ, Rubin SC and Boyd J (1996) Mutations of the BRCA2 gene in ovarian carcinomas. Cancer Res 56: 2738-2741
28. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell J, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder S, Steele L, Stringfellow M, Stroup C, Swedlund B, Swensen J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong A, Shizuya H, Eyfjord J, Cannon-Albright L, Skolnick M, Weber B, Kamb A and Goldgar D (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds (see comments). Nature Genet 12: 333-337
29. Teng DH, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanvvar S, Swedlund B, Wong AK and Kamb A (1996) Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature Genet 13: 241-244
30. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficence D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr N, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse CJ, Lynch H, Narod S, Lenoir GM, Egilsson V, Barkardottir RB, Easton DF, Bentley D, Futreal PA, Ashworth A and Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2 (see comments). Nature 378: 789-792
31. Yang Feng TL, Han H, Chen KC, Li SB, Claus EB, Carcangiu ML, Chambers SK, Chambers JT and Schwartz PE (1993) Allelic loss in ovarian cancer. Int J Cancer 54: 546-551
32. Yoshiura K, Kanai Y, Ochiai A, Shimoyama Y, Sugimura T and Hirohashi S (1995) Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 92: 7416-7419